An AMCP Virtual CPE Event.

10-11am ET: Satellite Symposium: Reducing Nonadherence and Rehospitalization Through Effective Tardive Dyskinesia Treatment

12-1pm ET: Precision at Scale: Translating the Evolving Biomarker Landscape in NSCLC Into Strategies for Timely and Targeted Care

2-3:15pm ET: Oncology Pipeline 2026: Advances, Trends, and Impact

4-5:30pm ET: Satellite Symposium: Navigating Payer Decisions in an Evolving Multiple Myeloma Treatment Landscape

A Science & Innovation Webinar, presented by Abbvie.

It is important to appropriately manage a person with migraine who experiences greater than 4 attacks a month (or severe disability from at least two attacks a month) and may benefit from preventive therapy. One of the main goals of preventive therapy is to improve function and reduce disability. Utilizing a stratified care approach to preventive migraine treatment is key to accomplish this goal.

Dr. Maureen Moriarty, a migraine expert, will:

• Discuss the complexity of migraine disease and the burden of the disease as it relates to function.

• Discuss the treatment guidelines for preventive treatment of migraine, with a focus on a treatment option with updated clinical data for migraine prevention.

An AMCP Member Webinar.

Join AMCP for a timely post-election webinar examining how the results of the 2026 elections may shape the future of health care policy. This session will provide an overview of key federal priorities expected to emerge in the new political landscape. Expert speakers will discuss how shifts in congressional and administrative leadership could influence legislative and regulatory activity, coverage policies, and patient access to medications.

A Pre-Approval Information Exchange (PIE) Webinar, presented by Intellia Therapeutics.

This presentation contains information about the investigational product lonvoguran ziclumeran (lonvo-z, also known as NTLA-2002) for the treatment of hereditary angioedema (HAE). Lonvo-z is investigational, has not received FDA-approval, and safety and efficacy have not been established. This presentation is intended only for payers, formulary committees or other similar entities responsible for the selection of drugs for coverage or reimbursement.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.

An AMCP CE Webinar.

Through a moderated panel discussion featuring experts from managed care, industry, and health policy, speakers will examine key themes related to the value, communication, credibility, and application of Patient Experience Data in coverage and formulary decision-making. The session will conclude with practical recommendations and future directions for advancing the meaningful use of patient experience data in payer decision-making.

An AMCP Market Insights Webinar.

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare immune-mediated neuropathy that can result in significant long-term disability if diagnosis and treatment are delayed. In this AMCP Market Insights webinar, Dr. Ehtesham Khalid reviews recent advances in the understanding of CIDP, including emerging insights into disease pathophysiology, diagnostic challenges, current standards of care, and investigational therapies. Drawing on findings from AMCP's May 2026 Market Insights roundtable, the program highlights issues relevant to managed care professionals, including treatment timing, evolving mechanisms of action, and considerations for future coverage and access decisions.

An AMCP Webinar.

Since its introduction in 2000, the AMCP Format for Formulary Submissions has become the primary tool for manufacturers to share safety, efficacy, and value data with health care decision-makers (HCDMs) as they consider products for coverage and formulary placement. In October, AMCP launched Format version 6.0.

This spotlight session will highlight updates made in version 6.0, including a discussion with an HCDM on how these updates will impact their review process. Future updates to the Format will also be discussed.